SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-023556
Filing Date
2024-02-14
Accepted
2024-02-14 16:00:57
Documents
1
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm246087-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm246087-2_4seq1.xml 4 14570
  Complete submission text file 0001104659-24-023556.txt   16004
Mailing Address 112 W. 34TH STREET, 17TH FLOOR NEW YORK NY 10120
Business Address
Dukes Iain D. (Reporting) CIK: 0001681955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 24637439

Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)